Pancreatic Cancer Research

ResearcherUniversidad de GranadaActive in the last 2 years

Esther Molina‐Montes

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0428-2426; OpenAlex author ID A5022325218, A5158642091. Sources: OpenAlex.

Their work

Papers
36 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
94
Papers, trials and grants by year

2011: 2 papers · 2012: 4 papers · 2013: 5 papers · 2014: 1 paper · 2015: 2 papers · 2016: 2 papers · 2017: 3 papers · 2018: 2 papers · 2019: 2 papers · 2020: 2 papers · 2021: 4 papers · 2022: 3 papers · 2023: none · 2024: none · 2025: 2 papers · 2026: 2 papers

Papers 36

  1. Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-026-69055-2↗
  2. A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study. Last author DOI 10.1158/1055-9965.epi-25-1601↗
  3. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-025-65811-y↗
  4. Sex Disparities and Female Reproductive and Hormonal Factors Associated with Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer an… Co-author DOI 10.3390/cancers17142275↗
  5. Inflammatory potential of diet and pancreatic cancer risk in the EPIC study. Co-author DOI 10.1007/s00394-022-02809-y↗
  6. Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study. Co-author DOI 10.1053/j.gastro.2022.03.054↗
  7. A faecal microbiota signature with high specificity for pancreatic cancer. Co-author DOI 10.1136/gutjnl-2021-324755↗
  8. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study. Co-author DOI 10.1097/cej.0000000000000588↗
  9. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. Co-author DOI 10.1136/gutjnl-2019-319990↗
  10. Are Circulating Immune Cells a Determinant of Pancreatic Cancer Risk? A Prospective Study Using Epigenetic Cell Count Measures. Co-author DOI 10.1158/1055-9965.epi-21-0169↗
  11. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  12. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. Co-author DOI 10.1158/1055-9965.epi-19-1027↗
  13. DNA Methylation-Derived Immune Cell Profiles, CpG Markers of Inflammation, and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0378↗
  14. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. Co-author DOI 10.1002/ijc.31866↗
  15. Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Co-author DOI 10.1136/gutjnl-2017-314828↗
  16. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. Co-author DOI 10.1093/ije/dyx269↗
  17. Response to: Variation of the age at onset of pancreatic cancer according to tobacco smoking and family history. Co-author DOI 10.1093/ije/dyy085↗
  18. Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Co-author DOI 10.1038/bjc.2017.14↗
  19. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk. Co-author DOI 10.1093/annonc/mdx167↗
  20. Genomics in Primary and Secondary Prevention of Pancreatic Cancer. First author DOI 10.1159/000477234↗
  21. Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.30190↗
  22. Sweet-beverage consumption and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Co-author DOI 10.3945/ajcn.116.130963↗
  23. Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutritio… Co-author DOI 10.1002/ijc.29175↗
  24. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCAR… Co-author DOI 10.1016/j.ejca.2015.07.034↗
  25. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Co-author DOI 10.1158/1055-9965.epi-14-0247↗
  26. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1002/ijc.27637↗
  27. Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and… Co-author DOI 10.1002/ijc.27875↗
  28. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition a… Co-author DOI 10.1016/j.cgh.2013.05.029↗
  29. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Co-author DOI 10.1093/annonc/mdt255↗
  30. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Co-author DOI 10.1136/gutjnl-2012-303006↗
  31. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort. Co-author DOI 10.1002/ijc.26244↗
  32. Plasma cotinine levels and pancreatic cancer in the EPIC cohort study. Co-author DOI 10.1002/ijc.26452↗
  33. Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.27547↗
  34. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1038/bjc.2012.19↗
  35. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into … Co-author DOI 10.1007/s00125-011-2316-0↗
  36. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1016/j.ejca.2011.02.007↗

Closest collaborators

The 25 strongest of 94 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Núria Malats Riera · 12 shared papers, 2017–2022 · strength 1.06
  2. Malin Sund · 17 shared papers, 2011–2025 · strength 0.60
  3. Weimin Ye · 18 shared papers, 2011–2021 · strength 0.59
  4. Alfredo Carrato Mena · 8 shared papers, 2017–2022 · strength 0.56
  5. Francisco X. Real · 8 shared papers, 2017–2022 · strength 0.56
  6. Verena Andrea Katzke · 9 shared papers, 2013–2025 · strength 0.54
  7. Paulina Gómez-Rubio · 7 shared papers, 2017–2022 · strength 0.50
  8. Rudolf Kaaks · 11 shared papers, 2011–2025 · strength 0.44
  9. Linda Sharp · 6 shared papers, 2017–2021 · strength 0.40
  10. Luis Muñoz‐Bellvís · 6 shared papers, 2017–2021 · strength 0.40
  11. J. Enrique Domínguez‐Muñoz · 6 shared papers, 2017–2021 · strength 0.40
  12. William Greenhalf · 6 shared papers, 2017–2021 · strength 0.40
  13. Jorg H. Kleeff · 6 shared papers, 2017–2021 · strength 0.40
  14. Matthias J. Löhr · 6 shared papers, 2017–2021 · strength 0.40
  15. Bo Kong · 6 shared papers, 2017–2021 · strength 0.40
  16. Tatjana Crnogorac‐Jurcevic · 6 shared papers, 2017–2021 · strength 0.40
  17. Thomas Mathias Gress · 6 shared papers, 2017–2021 · strength 0.40
  18. Aldo Scarpa Scarpa · 6 shared papers, 2017–2021 · strength 0.40
  19. Eithne Costello · 6 shared papers, 2017–2021 · strength 0.40
  20. Eric J. Duell · 16 shared papers, 2011–2017 · strength 0.39
  21. Elio Ríboli · 16 shared papers, 2011–2017 · strength 0.39
  22. Marta Crous‐Bou · 3 shared papers, 2021–2025 · strength 0.36
  23. Christoph W. Michalski · 5 shared papers, 2018–2021 · strength 0.36
  24. H. Bas Bueno-de-Mesquita · 14 shared papers, 2011–2017 · strength 0.35
  25. Federico Canzian · 5 shared papers, 2012–2025 · strength 0.32

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.